FDA to Revisit Abuse-Deterrence Data for Opioid Drugs

(MedPage Today) -- Two-day meeting in July to scrutinize data sources, methods to determine real-world impact
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news